lorazepam has been researched along with Hyperparathyroidism, Primary in 1 studies
Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.
Hyperparathyroidism, Primary: A condition of abnormally elevated output of PARATHYROID HORMONE due to parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. It is characterized by the combination of HYPERCALCEMIA, phosphaturia, elevated renal 1,25-DIHYDROXYVITAMIN D3 synthesis, and increased BONE RESORPTION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Parks, KA | 1 |
| Parks, CG | 1 |
| Onwuameze, OE | 1 |
| Shrestha, S | 1 |
1 other study available for lorazepam and Hyperparathyroidism, Primary
| Article | Year |
|---|---|
Psychiatric Complications of Primary Hyperparathyroidism and Mild Hypercalcemia.
Topics: Aged, 80 and over; Antipsychotic Agents; Depressive Disorder, Major; Female; GABA Modulators; Humans | 2017 |